NCT03812549 2025-03-04Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC PatientsSichuan UniversityPhase 1 Completed29 enrolled 11 charts
NCT03150875 2023-02-28A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLCInnovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed290 enrolled 14 charts